How to read these charts
Against the national standards
Each measure is drawn against its own NHS England standard: 95% for A&E within four hours, 85% for urgent cancer treatment within sixty-two days and 99% for diagnostic tests within six weeks. The charts do not share a standard and the three cancer measures are never added together.
Care Quality Commission
When CQC last rated this body
CQC has not rated Homerton Healthcare NHS Foundation Trust since 10 August 2018. Its judgements from then are still on CQC’s own site and are not shown here, because a rating more than 3 years old is not what CQC currently says about a body.
Monthly performance against national standards
Hover or use the arrow keys to read any month, with the figures the percentage was worked out from. Every chart opens as a table.
A&E Wait Times
Patients seen within four hours
83.4%
August 2026: 83.4 per cent, 9,297 of 11,151 attendances. Below the 95% standard.
All 17 months as a table
| Month | Performance | Of attendances |
|---|---|---|
| Aug 2026 | 83.4%, Below the 95% standard | 9,297 of 11,151 |
| Jul 2026 | 79.1%, Below the 95% standard | 9,098 of 11,507 |
| Jun 2026 | 80.3%, Below the 95% standard | 9,270 of 11,549 |
| May 2026 | 79.4%, Below the 95% standard | 9,275 of 11,679 |
| Apr 2026 | 79.5%, Below the 95% standard | 8,829 of 11,100 |
| Mar 2026 | 85.1%, Below the 95% standard | 9,751 of 11,459 |
| Feb 2026 | 83.5%, Below the 95% standard | 8,491 of 10,173 |
| Jan 2026 | 78.8%, Below the 95% standard | 8,927 of 11,326 |
| Dec 2025 | 81.5%, Below the 95% standard | 9,034 of 11,082 |
| Nov 2025 | 83.3%, Below the 95% standard | 9,410 of 11,300 |
| Oct 2025 | 79.6%, Below the 95% standard | 9,196 of 11,547 |
| Sept 2025 | 82.1%, Below the 95% standard | 8,943 of 10,890 |
| Aug 2025 | 81.1%, Below the 95% standard | 8,385 of 10,343 |
| Jul 2025 | 81.2%, Below the 95% standard | 9,281 of 11,437 |
| Jun 2025 | 80.3%, Below the 95% standard | 8,891 of 11,079 |
| May 2025 | 82.5%, Below the 95% standard | 9,372 of 11,355 |
| Apr 2025 | 82.0%, Below the 95% standard | 8,837 of 10,777 |
Waiting times (RTT)
Referral to treatment: waiting under eighteen weeks to start treatment
73.6%
July 2026: 73.6 per cent, 19,238 of 26,141 people waiting. Below the 92% standard.
All 14 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 73.6%, Below the 92% standard | 19,238 of 26,141 |
| Jun 2026 | 75.4%, Below the 92% standard | 20,262 of 26,863 |
| May 2026 | 75.9%, Below the 92% standard | 20,838 of 27,439 |
| Apr 2026 | 76.3%, Below the 92% standard | 20,475 of 26,849 |
| Mar 2026 | 76.6%, Below the 92% standard | 20,121 of 26,282 |
| Feb 2026 | 73.7%, Below the 92% standard | 18,547 of 25,171 |
| Jan 2026 | 71.1%, Below the 92% standard | 17,406 of 24,474 |
| Dec 2025 | 69.8%, Below the 92% standard | 17,403 of 24,914 |
| Nov 2025 | 68.4%, Below the 92% standard | 19,026 of 27,827 |
| Oct 2025 | 67.4%, Below the 92% standard | 20,717 of 30,726 |
| Sept 2025 | 66.3%, Below the 92% standard | 21,982 of 33,155 |
| Aug 2025 | 65.3%, Below the 92% standard | 22,425 of 34,340 |
| Jul 2025 | 65.0%, Below the 92% standard | 23,065 of 35,456 |
| Jun 2025 | 64.9%, Below the 92% standard | 23,454 of 36,119 |
Diagnostic tests (DM01)
Waiting under six weeks for a scan, a scope or a test
97.0%
July 2026: 97.0 per cent, 7,693 of 7,928 people waiting. Below the 99% standard.
All 4 months as a table
| Month | Performance | Of people waiting |
|---|---|---|
| Jul 2026 | 97.0%, Below the 99% standard | 7,693 of 7,928 |
| Jun 2026 | 98.2%, Below the 99% standard | 8,369 of 8,526 |
| May 2026 | 97.8%, Below the 99% standard | 8,094 of 8,276 |
| Apr 2026 | 97.0%, Below the 99% standard | 8,126 of 8,375 |
Cancer diagnosis (FDS)
Faster diagnosis standard: told the outcome within twenty-eight days
87.2%
July 2026: 87.2 per cent, 1,377 of 1,580 referrals. Meets the 75% standard.
All 7 months as a table
| Month | Performance | Of referrals |
|---|---|---|
| Jul 2026 | 87.2%, Meets the 75% standard | 1,377 of 1,580 |
| Jun 2026 | 86.2%, Meets the 75% standard | 1,363 of 1,582 |
| May 2026 | 85.7%, Meets the 75% standard | 1,170 of 1,365 |
| Apr 2026 | 82.4%, Meets the 75% standard | 1,289 of 1,565 |
| Mar 2026 | 81.9%, Meets the 75% standard | 1,257 of 1,534 |
| Feb 2026 | 84.3%, Meets the 75% standard | 1,169 of 1,387 |
| Jan 2026 | 80.4%, Meets the 75% standard | 1,040 of 1,294 |
Cancer (31-day)
Decision to treat to first treatment within thirty-one days
100.0%
July 2026: 100.0 per cent, 59 of 59 treatments. Meets the 96% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 100.0%, Meets the 96% standard | 59 of 59 |
| Jun 2026 | 100.0%, Meets the 96% standard | 75 of 75 |
| May 2026 | 100.0%, Meets the 96% standard | 59 of 59 |
| Apr 2026 | 100.0%, Meets the 96% standard | 67 of 67 |
| Mar 2026 | 98.5%, Meets the 96% standard | 66 of 67 |
| Feb 2026 | 100.0%, Meets the 96% standard | 49 of 49 |
| Jan 2026 | 100.0%, Meets the 96% standard | 65 of 65 |
Cancer (62-day)
Urgent referral to first treatment within sixty-two days
88.3%
July 2026: 88.3 per cent, 53 of 60 treatments. Meets the 85% standard.
All 7 months as a table
| Month | Performance | Of treatments |
|---|---|---|
| Jul 2026 | 88.3%, Meets the 85% standard | 53 of 60 |
| Jun 2026 | 87.8%, Meets the 85% standard | 68.5 of 78 |
| May 2026 | 89.8%, Meets the 85% standard | 48.5 of 54 |
| Apr 2026 | 86.1%, Meets the 85% standard | 62 of 72 |
| Mar 2026 | 86.6%, Meets the 85% standard | 58 of 67 |
| Feb 2026 | 85.0%, Meets the 85% standard | 42.5 of 50 |
| Jan 2026 | 90.3%, Meets the 85% standard | 56 of 62 |
